Our Services/Safety & Compliance/

Literature Monitoring & Surveillance

Proactive Safety Intelligence from Global Scientific Sources

Ensure continuous monitoring Get in touch

Medical literature is a critical source of safety information and plays a key role in maintaining an accurate and up-to-date benefit–risk profile of medicinal products. Baupharma’s literature monitoring services are designed to systematically identify, evaluate, and report safety data from global and local sources, ensuring continuous compliance with pharmacovigilance services requirements.

1000+Sources of literature
screening Monthly

We deliver high-quality, audit-ready outputs that support both regulatory obligations and strategic decision-making by combining:

  • Scientific Expertise
  • Structured Methodologies
  • Advanced Tools

Global Literature Surveillance

Baupharma conducts structured and periodic searches across major biomedical databases such as PubMed, Embase, and Medline to identify relevant publications, including potential safety cases and emerging risks.

Weekly or periodic database screening aligned with regulatory expectations

Identification of Individual Case Safety Reports (ICSR)

Abstract review and relevance assessment based on GVP criteria

Local Literature Monitoring

Baupharma's services extend beyond indexed databases to include non-indexed journals, regional publications, and country-specific sources. This ensures comprehensive coverage across all markets where products are authorized.

Local Intelligence.
Global Reach.

Monitoring of local journals and scientific publications

Multilingual review by local experts and native speakers

Coverage tailored to therapeutic areas and product portfolios

Coordination between global and local teams for consistent outputs

Targeted & Ad Hoc Literature Searches

Baupharma performs customized literature searches to support specific pharmacovigilance activities, regulatory submissions, and safety evaluations.

  • Signal detection and validation activities
  • Support for aggregate reports (e.g., PSUR/PBRER, DSUR)
  • Literature reviews for risk management and benefit–risk evaluation
  • Investigation of specific safety concerns or product queries

Safety Data Extraction & Case Identification

Our teams are trained to identify and extract safety-relevant information from literature sources, ensuring accurate and compliant reporting into pharmacovigilance systems.

Key responsibilities include:

1.

Identification and processing of reportable safety cases

2.

Classification of special situations (e.g., off-label use, misuse)

3.

Integration with case processing workflows

4.

Timely escalation and reporting in line with regulatory timelines

Integrated Signal Management & Risk Evaluation

Literature monitoring that is fully aligned with broader pharmacovigilance activities, contributing directly to signal detection, risk management, and safety communication strategies.

Our Strategy includes:

Input into signal detection and validation processes

Support for benefit–risk assessments across the product lifecycle

Contribution to post-authorization safety studies (PASS)

Evidence generation for regulatory and clinical decision-making

Technology-Enabled Monitoring & Quality Control

Baupharma leverages a combination of automation and expert medical review to enhance efficiency while maintaining high data quality.

Our Approach includes:

Automated search strategies combined with manual validation

Optimized search queries tailored to product and drug class

Quality control checks to ensure completeness and accuracy

Structured reporting and full traceability for audit readiness

Seamless Integration with Your PV System

Our literature monitoring services are fully integrated into the pharmacovigilance framework, ensuring smooth data flow and consistency across all safety activities.

Our Pharmacovigilance Framework

Alignment with case processing and safety databases

Collaboration with medical writing and signal management teams

Continuous communication and reporting

Compliance with global Good Pharmacovigilance Practices (GVP)

Flexible Delivery Models Baupharma offers scalable solutions tailored to operational needs:

Fully Outsourced Mode

Full outsourcing of literature monitoring activities

Hybrid Model

Hybrid models integrated with internal PV teams

Targeted Support

Support for specific products, portfolios, or regions

Identify emerging safety signals early

Partner with us for reliable insights

Why Partner With Us ?Your Trusted Pharmacovigilance Partner

Global and local coverage with multilingual expertise

Scientifically trained teams with PV specialization

Strong regulatory compliance and inspection readiness

Tailored strategies aligned with product portfolio

Technology-driven processes for efficiency and accuracy

Turning Literature into Actionable Safety Insights

Baupharma goes beyond literature screening, transforming scientific publications into meaningful safety intelligence that supports compliance, strengthens risk management, and ultimately enhances patient safety.

NEXT IN SAFETY & COMPLIANCE

Case Processing (ICSR Management)

Accurate Safety Data. Timely Reporting. Full Compliance.

Ready To Simplify Your Journey?

Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.

Request Free Consultation Submit RFI/RFP

No commitment required
48h response time